The Legionella Testing market size was USD 306.29 million in 2023 and is expected to reach USD 650.82 million by 2032 and grow at a CAGR of 8.74% over the forecast period of 2024-2032. This report provides a comprehensive analysis of the legionella testing market, highlighting key trends such as the rising incidence of Legionnaires’ disease and the increasing adoption of rapid diagnostic methods like PCR testing. It examines the regulatory landscape, detailing compliance rates and enforcement measures across regions. The report also explores testing volume growth, end-user adoption trends, and advancements in testing technologies. Additionally, it covers water contamination statistics, investment in R&D, and pricing trends in the market. A detailed assessment of testing method adoption rates, along with industry-specific demand from healthcare, hospitality, and industrial sectors, is included. The study also presents a cost analysis of various testing methods and their regional variations. Overall, this report delivers critical insights into market dynamics, innovation, and regulatory impact shaping the legionella testing industry.
The Legionella Market size in the U.S. was USD 95.4 million in 2023 and is expected to reach USD 180.1 million by 2032, growing at a CAGR of 7.31% over the forecast period of 2024-2032. The U.S. held the largest market share in the North American naphtha market, accounting for 76% market share in 2023 due to its extensive refining capacity, strong petrochemical industry, and high demand for gasoline blending. The country has one of the largest refinery infrastructures globally, enabling the production of large volumes of naphtha to support its industrial and energy sectors. The presence of major petrochemical hubs along the Gulf Coast, where naphtha is a key feedstock for ethylene and propylene production, has further strengthened its dominance. Additionally, the U.S. benefits from an abundant supply of shale oil and natural gas liquids, which enhances its refining efficiency and cost competitiveness. Rising exports of naphtha to Asia and Europe, along with increasing domestic demand from the automotive and packaging industries, have further solidified the U.S. position as the market leader in North America.
Drivers
Stringent water safety regulations and rising legionnaires’ disease cases drive the legionella testing market growth.
The growing number of Legionnaires’ disease cases worldwide has led to stricter water safety regulations, significantly driving demand for Legionella testing. Regulatory bodies, such as the U.S. Environmental Protection Agency (EPA), the Centers for Disease Control and Prevention (CDC), and the European Centre for Disease Prevention and Control (ECDC), have enforced stringent guidelines for monitoring Legionella contamination in water systems. These regulations mandate frequent testing in high-risk environments like hospitals, hotels, and industrial cooling towers. Additionally, rising public awareness about the health risks associated with Legionella-contaminated water has further fueled market growth. As a result, industries are increasingly adopting rapid diagnostic methods, including PCR and antigen-based tests, to ensure compliance with safety standards. This heightened regulatory scrutiny, coupled with advancements in Legionella detection technologies, continues to propel market expansion.
Restrain
High costs of advanced legionella testing methods limit market adoption in cost-sensitive regions.
Despite the growing demand for Legionella testing, the high costs associated with advanced diagnostic techniques remain a significant restraint. PCR-based and next-generation sequencing (NGS) methods, while highly accurate and efficient, require expensive laboratory equipment, skilled personnel, and specialized reagents, making them financially challenging for small-scale water testing facilities and low-income regions. Traditional culture-based methods, although more affordable, have longer turnaround times, delaying critical responses to Legionella outbreaks. Moreover, regulatory compliance costs add financial burdens to industries required to conduct regular Legionella testing. Small and medium-sized businesses, particularly in developing countries, often struggle to meet these requirements due to budget constraints. As a result, the adoption of cost-effective testing solutions remains a key challenge, limiting the broader expansion of the Legionella testing market in cost-sensitive regions.
Opportunity
The rising adoption of automated and AI-powered water testing solutions creates growth opportunities for the legionella testing market.
The increasing integration of automation and artificial intelligence (AI) in water testing presents a significant growth opportunity for the Legionella testing market. Advanced automated testing solutions, including AI-powered real-time water monitoring systems, can detect Legionella contamination with high accuracy and minimal human intervention. These innovations enable faster, more efficient testing, reducing delays associated with traditional laboratory-based methods. Furthermore, the growing adoption of Internet of Things (IoT)-enabled water quality monitoring systems in industrial and commercial settings has enhanced proactive Legionella detection. Governments and private enterprises are investing in smart water management technologies to ensure compliance with stringent safety regulations. As AI-driven diagnostic tools become more affordable and accessible, the market is expected to witness increased adoption, particularly in industries such as healthcare, hospitality, and municipal water treatment.
Challenge
Challenges in standardizing global legionella testing regulations across different regions and industries.
One of the major challenges in the Legionella testing market is the lack of standardized global regulations across various regions and industries. While developed nations such as the U.S., Canada, and European countries have stringent guidelines for Legionella monitoring, many emerging economies still lack well-defined regulatory frameworks. This inconsistency leads to varying testing frequencies, methodologies, and compliance requirements across different sectors. Additionally, some industries, such as healthcare and hospitality, are subject to stricter monitoring compared to others, creating disparities in testing adoption. The absence of universally accepted standards complicates the implementation of effective Legionella control measures, as businesses operating in multiple regions must navigate different regulatory landscapes. Addressing this challenge requires coordinated efforts from international health organizations, regulatory bodies, and industry stakeholders to establish uniform guidelines for Legionella testing worldwide.
By Type
Water Testing held the largest market share, around 67%, in 2023. It is due to legionella bacteria that can be found in water systems like cooling towers, plumbing networks, hot water tanks, and industrial water supplies. regular testing is a requirement for compliance with strict safety standards. To keep Legionella out of buildings like hospitals, hotels, and many commercial buildings, regulators including the EPA, CDC, and WHO, require regular water testing in these environments. Moreover, the growing demand for rapid and automated water testing solutions, including PCR (Polymerase chain reaction) based tests and antigen detection tests, is anticipated to fuel the market growth over the forecast period. The continuous increase in public awareness of waterborne diseases, along with the growing availability of real-time water-monitoring technologies, has lent yet more support to the established dominance of water testing, establishing it as the most common Legionella detection method.
By End-Use
Microbial Culture held the largest market share in the legionella testing market around 39% in 2023. It is due to its status as the gold standard for Legionella detection, widely recognized by regulatory agencies such as the CDC, EPA, and WHO. This method is highly reliable for identifying viable and infectious Legionella bacteria, making it essential for regulatory compliance in water safety programs. Despite the emergence of rapid diagnostic techniques like PCR and DFA stain, microbial culture remains the preferred choice due to its ability to differentiate live bacteria from dead cells, ensuring accurate risk assessment. Additionally, its widespread adoption in hospitals, water treatment facilities, and industrial sites reinforces its market dominance. While the method has a longer turnaround time, its cost-effectiveness and regulatory acceptance contribute to its continued leadership in the Legionella testing market.
Europe held the largest market share at around 42% in 2023. This is owing to stringent regulations set for water safety, high level of awareness regarding legionella-related risks, and well-established healthcare infrastructure. Legionella testing is required in industries like healthcare, hospitality and water treatment facilities by regulatory bodies like the European Centre for Disease Prevention and Control (ECDC) and the Health and Safety Executive (HSE) in the U.K. There have also been more cases of Legionnaires’ disease in Europe and therefore buildings are being tested more regularly in both the public and private sector. Innovation is another area where the region excels, with PCR-based rapid diagnostics and mechanization and auto water monitoring techniques. In addition to this, the commercialization of waterborne disease prevention along with stringent compliance requirements has propelled the demand for Legionella testing in the region, which has established Europe as a leading market across the globe.
Asia Pacific held the significant market share. This is due to the strengthening of water quality guidelines for controlling Legionella outbreaks in China, Japan, India, and Australia, which has led to stringent regulations in the healthcare, hospitality, and manufacturing industries. This wide range of applications from land to water and the exponential growth of cooling towers, water treatment facilities, and public water systems have created a significant demand for routine testing. Moreover, there is also growing utilization of these advanced testing technologies like PCR-based detection, automated water testing solutions, etc. In addition, its wide market share can also be attributed to its huge population, rapidly developing healthcare infrastructure, and foreign investments in water safety projects.
Aquacert Ltd (Legionella Water Testing Kits, Lab Analysis Services)
Quidel Corporation (Lyra Direct Legionella Assay, Sofia FIA System)
Merck KGaA (Legiolert Test, Singlepath Legionella)
Thermo Fisher Scientific Inc. (SureTect PCR System, Remel Legionella Latex Test)
bioMérieux (VIDAS Legionella, GENE-UP Legionella)
Eurofins Scientific (Legionella Culture Testing, qPCR Legionella Testing)
Abbott (Alere Legionella, BinaxNOW Legionella Urinary Antigen Card)
Bio-Rad Laboratories, Inc. (iQ-Check Legionella Kit, RAPID Legionella Medium)
BD (BD MAX System, Legionella DFA Test)
IDEXX Corporation (Legiolert, Colilert-18)
Pall Corporation (Legionella Detection Filtration Kits, Ultrafiltration Systems)
NEOGEN Corporation (Legionella qPCR Detection Kit, LuminUltra Test Kit)
Hygiena (EnSURE Touch, Innovate System)
LuminUltra (GeneCount Legionella Testing, LuminUltra qPCR Kits)
Water Treatment Products Ltd. (Legionella Rapid Test Kit, Potable Water Testing Kit)
ALS Limited (Legionella Culture Testing, PCR Legionella Analysis)
MP Biomedicals (Legionella DFA Kit, Legionella PCR Assay)
Camlab (Legionella Field Testing Kit, Water Test Strips)
Pro-Lab Diagnostics (Legionella Latex Test Kit, Microgen Legionella ID Panel)
Veolia Water Technologies (Legionella Risk Assessment, On-Site Legionella Testing Services)
In 2024, Eurofins Scientific, in collaboration with industry partners, led Eurofins IPROMA in developing advanced biosensors designed for detecting Legionella pneumophila in water systems, improving rapid detection and prevention strategies.
In 2023, LuminUltra introduced BugCount Guardian, an advanced version of their 2nd Generation ATP testing, providing fast and reliable microbial monitoring solutions for water systems.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 306.29 Million |
| Market Size by 2032 | USD650.82 Million |
| CAGR | CAGR of8.74 % From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type (Water Testing, IVD Testing) • By End-Use (Microbial Culture, Direct Fluorescent Antibody (DFA) Stain, PCR, Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Aquacert Ltd, Quidel Corporation, Merck KGaA, Thermo Fisher Scientific Inc., bioMérieux, Eurofins Scientific, Abbott, Bio-Rad Laboratories, Inc., BD, IDEXX Corporation, Pall Corporation, NEOGEN Corporation, Hygiena, LuminUltra, Water Treatment Products Ltd., ALS Limited, MP Biomedicals, Camlab, Pro-Lab Diagnostics, Veolia Water Technologies |
Ans: The Legionella Testing Market was valued at USD 306.29 Million in 2023.
Ans: The expected CAGR of the global Legionella Testing Market during the forecast period is 8.74%
Ans: Water Testing will grow rapidly in the Legionella Testing Market from 2024 to 2032.
Ans: Stringent water safety regulations and rising legionnaires’ disease cases drive the legionella testing market growth.
Ans: Europe led the Legionella Testing Market in the region with the highest revenue share in 2023.
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Investment & R&D Trends
5.2 Regulatory & Compliance Statistics
5.3 Infection & Outbreak Data
5.4 Testing Method Adoption Rates
6. Competitive Landscape
6.1 List of Major Companies By Region
6.2 Market Share Analysis By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion Plans and New Product Launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Legionella Testing Market Segmentation By Type
7.1 Chapter Overview
7.2 Water Testing
7.2.1 Water Testing Trend Analysis (2020-2032)
7.2.2 Water Testing Market Size Estimates and Forecasts to 2032 (USD Million)
7.3 IVD Testing
7.3.1 IVD Testing Market Trends Analysis (2020-2032)
7.3.2 IVD Testing Market Size Estimates and Forecasts to 2032 (USD Million)
8. Legionella Testing Market Segmentation, By End-Use
8.1 Chapter Overview
8.2 Microbial Culture
8.2.1 Microbial Culture Market Trends Analysis (2020-2032)
8.2.2 Microbial Culture Market Size Estimates and Forecasts to 2032 (USD Million)
8.3 Direct Fluorescent Antibody (DFA) Stain
8.3.1 Direct Fluorescent Antibody (DFA) Stain Market Trends Analysis (2020-2032)
8.3.2 Direct Fluorescent Antibody (DFA) Stain Market Size Estimates and Forecasts to 2032 (USD Million)
8.4 PCR
8.4.1 PCR Market Trends Analysis (2020-2032)
8.4.2 PCR Market Size Estimates and Forecasts to 2032 (USD Million)
8.4 Others
8.4.1 Others Market Trends Analysis (2020-2032)
8.4.2 Others Market Size Estimates and Forecasts to 2032 (USD Million)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Legionella Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.2.3 North America Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.2.4 North America Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.2.5 USA
9.2.5.1 USA Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.2.5.2 USA Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.2.6 Canada
9.2.6.1 Canada Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.2.6.2 Canada Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.2.7 Mexico
9.2.7.1 Mexico Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.2.7.2 Mexico Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe Legionella Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.3.1.3 Eastern Europe Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.1.4 Eastern Europe Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.1.5 Poland
9.3.1.5.1 Poland Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.1.5.2 Poland Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.1.6 Romania
9.3.1.6.1 Romania Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.1.6.2 Romania Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.1.7 Hungary
9.3.1.7.1 Hungary Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.1.7.2 Hungary Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.1.8 Turkey
9.3.1.8.1 Turkey Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.1.8.2 Turkey Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.1.9.2 Rest of Eastern Europe Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe Legionella Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.3.2.3 Western Europe Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.2.4 Western Europe Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.2.5 Germany
9.3.2.5.1 Germany Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.2.5.2 Germany Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.2.6 France
9.3.2.6.1 France Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.2.6.2 France Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.2.7 UK
9.3.2.7.1 UK Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.2.7.2 UK Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.2.8 Italy
9.3.2.8.1 Italy Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.2.8.2 Italy Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.2.9 Spain
9.3.2.9.1 Spain Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.2.9.2 Spain Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.2.10.2 Netherlands Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.2.11 Switzerland
9.3.2.11.1 Switzerland Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.2.11.2 Switzerland Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.2.12 Austria
9.3.2.12.1 Austria Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.2.12.2 Austria Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.2.13 Rest of Western Europe
9.3.2.13.1 Rest of Western Europe Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.2.13.2 Rest of Western Europe Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Legionella Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.4.3 Asia Pacific Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.4.4 Asia Pacific Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.4.5 China
9.4.5.1 China Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.4.5.2 China Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.4.6 India
9.4.5.1 India Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.4.5.2 India Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.4.5 Japan
9.4.5.1 Japan Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.4.5.2 Japan Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.4.6 South Korea
9.4.6.1 South Korea Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.4.6.2 South Korea Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.4.7 Vietnam
9.4.7.1 Vietnam Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.2.7.2 Vietnam Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.4.8 Singapore
9.4.8.1 Singapore Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.4.8.2 Singapore Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.4.9 Australia
9.4.9.1 Australia Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.4.9.2 Australia Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.4.10 Rest of Asia Pacific
9.4.10.1 Rest of Asia Pacific Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.4.10.2 Rest of Asia Pacific Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East Legionella Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.5.1.3 Middle East Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.5.1.4 Middle East Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.5.1.5 UAE
9.5.1.5.1 UAE Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.5.1.5.2 UAE Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.5.1.6 Egypt
9.5.1.6.1 Egypt Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.5.1.6.2 Egypt Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.5.1.7 Saudi Arabia
9.5.1.7.1 Saudi Arabia Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.5.1.7.2 Saudi Arabia Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.5.1.8 Qatar
9.5.1.8.1 Qatar Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.5.1.8.2 Qatar Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.5.1.9.2 Rest of Middle East Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa Legionella Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.5.2.3 Africa Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.5.2.4 Africa Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.5.2.5 South Africa
9.5.2.5.1 South Africa Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.5.2.5.2 South Africa Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.5.2.6 Nigeria
9.5.2.6.1 Nigeria Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.5.2.6.2 Nigeria Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Legionella Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.6.3 Latin America Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.6.4 Latin America Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.6.5 Brazil
9.6.5.1 Brazil Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.6.5.2 Brazil Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.6.6 Argentina
9.6.6.1 Argentina Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.6.6.2 Argentina Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.6.7 Colombia
9.6.7.1 Colombia Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.6.7.2 Colombia Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.6.8 Rest of Latin America
9.6.8.1 Rest of Latin America Legionella Testing Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.6.8.2 Rest of Latin America Legionella Testing Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
10. Company Profiles
10.1 Aquacert Ltd
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Product / Services Offered
10.1.4 SWOT Analysis
10.2 Quidel Corporation
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Product/ Services Offered
10.2.4 SWOT Analysis
10.3 Merck KGaA
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Product/ Services Offered
10.3.4 SWOT Analysis
10.4 Thermo Fisher Scientific Inc.
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Product/ Services Offered
10.4.4 SWOT Analysis
10.5 BioMérieux
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Product/ Services Offered
10.5.4 SWOT Analysis
10.6 Eurofins Scientific
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Product/ Services Offered
10.6.4 SWOT Analysis
10.7 Abbott
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Product/ Services Offered
10.7.4 SWOT Analysis
10.8 Bio-Rad Laboratories, Inc.
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Product/ Services Offered
10.8.4 SWOT Analysis
10.9 BD
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Product/ Services Offered
10.9.4 SWOT Analysis
10.10 IDEXX Corporation
10.10.1 Company Overview
10.10.2 Financial
10.10.3 Product/ Services Offered
10.10.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Type
Water Testing
IVD Testing
By End-Use
Microbial Culture
Direct Fluorescent Antibody (DFA) Stain
PCR
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The Transfection Reagents & Equipment Market was USD 1.26 Billion in 2023, projected to reach USD 2.54 Billion by 2032 with a CAGR of 8.12% from 2024-2032.
The Burn Care Market size was valued at USD 3.10 Billion in 2023. It is estimated to reach USD 5.70 Billion by 2032, growing at a CAGR of 7.02% during 2024-2032.
The Electric Wheelchair Market was valued at USD 3.66 billion in 2023 and is expected to reach USD 9.82 billion by 2032, growing at a CAGR of 11.50% from 2024 to 2032.
The Anastomosis Devices Market Size was valued at USD 3.61 billion in 2023 and is expected to reach USD 6.63 billion by 2032 and grow at a CAGR of 7.01% over the forecast period 2024-2032.
The Precision Oncology Market Size was valued at USD 100.94 Billion in 2023, and is expected to reach USD 217.61 Billion by 2032, and grow at a CAGR of 9.35%.
The Pressure Monitoring Market was valued at USD 12.74 billion in 2023 and is expected to reach USD 27.07 billion by 2032, growing at a CAGR of 8.75% over the forecast period of 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
